Reuters logo
BRIEF-Adocia announces two projects for the treatment of type 1 diabetes
January 5, 2017 / 5:24 PM / in a year

BRIEF-Adocia announces two projects for the treatment of type 1 diabetes

Jan 5 (Reuters) - Adocia SA :

* Adocia announces two new multi-hormonal combination projects for the treatment of type 1 diabetes

* Medical benefit of such combinations already established in type 1 diabetes clinical trials with separate injections

* First clinical study expected to start in Q4 2017.

* New projects aim to offer more efficient therapy to people living with type 1 diabetes without increasing number of injections.

* Biochaperone enables combinations of insulin lispro with pramlintide and insulin lispro with exenatide, three hormones approved for treatment of diabetes Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below